As both hormones are used in the therapy of T2D, we tested how they would affect the hypothalamic expression of UGN by i.n. (central) application of insulin and liraglutide (GLP-1 analog) in 2-month-old WT mice. Here, INS is linked to type 2 diabetes mellitus.